Oxymetazoline Versus Sodium Hypochlorite as Hemostatic Agents in MTA Pulpotomy of Primary Molars

ConditionsPulp Disease, Dental Pulp Therapy in Primary Molars Pulpitis - Reversible Pulp Inflammation Vital Pulp Therapies Carious Exposure of Pulp Primary Molar Tooth Primary Molar Pulpotomy

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age4-8

SponsorCairo University

About this trial

This study aims to evaluate clinical and radiographic success of oxymetazoline versus sodium hypochlorite as hemostatic agents in MTA pulpotomy of primary molars.

Eligibility criteria

Qualifiers

None

Disqualifiers

Uncooperative children.

Medically compromised children.

Patients whose parents refuse to participate or refuse to sign the informed consent.

Previously accessed molars.

Trial design

Treatments tested in this trial

Oxymetazoline 0.05% nasal solution
Sodium Hypochlorite Solution

Treatment groups

50 Participants

are divided into 2 treatment groups

Sponsors and collaborators

Cairo University

Lead sponsor

Source ClinicalTrials.gov